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Background: 
Atopic Eczema (AE) is characterized by chronic inflammation and cutaneous 
hyperreactivity towards environmental stimuli. It is often the initial step in "atopy 
march", which leads to subsequent development of asthma and allergic rhinitis in a 
majority of patients. Current evidence suggests that epidermal barrier dysfunction is 
the major predisposing factor for AE, with an increased skin penetration leading to 
sensitization of antigen-presenting cells. AE has also been reported to have a strong 
genetic predisposition, with an increased level of phenotype concordance in 
monozygotic than dizygotic twins. The complex interaction between genetic and 
environmental factors causes allergy, and innate immune dysregulation also plays an 
indispensable role in its pathogenesis. 
Chitin is the second most abundant biopolymer found extensively in pathogens, 
making it an important molecule for host recognition and defense. Chitin can be 
degraded by species and evolutionary conserved enzymes, called chitinases (CHIAs). 
Acid mammalian chitinase (AMCase) is a CHIA with crucial roles in the 
development of murine asthma. As asthma and AE are closely related atopic diseases, 
we hypothesized that AE phenotypes are also associated with genetic variations of 
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the gene encoding AMCase. 
This hypothesis was supported by the presence of IgE antibodies specific to two 
insect CHIA homologous proteins in the sera of Dermatophagoides farinae 
sensitized dogs. Intradermal testing with the two purified proteins led to a positive 
reaction in D. farinae sensitized canines but not in the normal dogs. This suggested 
that CHIA is likely a major allergen for canine AE. Based on these preliminary 
observations, we hypothesized that CHIA also plays a crucial role in the pathogenesis 
of human AE. 
Objectives: 
This study aimed to investigate the association between Single-Nucleotide 
Polymorphisms (SNPs) of AMCase and childhood AE in Hong Kong Chinese 
children. 
Methods: 
AE was diagnosed according to Hanifin and Rajka's criteria. Peripheral blood 
eosinohil level, serum IgE, scoring atopic dermatitis (SCORAD), Nottingham 
eczema severity score (NESS), cutaneous Staphylococcus aureus carriage, as well as 
SH and TEWL were also assessed. Genomic DNA was extracted from peripheral 
blood, and genotyped for AMCase polymorphisms. Specific pairs of primer were 
used to amplify the sites of interest through polymerase chain reaction (PCR), 
followed by restriction fragment length polymorphism (RFLP) with alleles specific 
restriction enzymes. Four SNPs: rs3806448, rs3806446, rs3818822 and rs2282290 
were genotyped. The RFLP result was further confirmed by direct sequencing of 
AMCase in 5% of the randomly selected subjects. 
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Results: 
A total of 218 AE Chinese children were recruited from the paediatric 
dermatology clinic of the Prince of Wales Hospital, while 192 non-allergic controls 
were recruited from the community. This study revealed the following findings: (i) In 
terms of allele frequency distribution, the results from the binary logistic regression 
analysis suggested that rs3 806448 polymorphism may alter the AMCase expression 
level, (ii) the results from conducting maximum likelihood algorithm for estimating 
haplotype frequency showed that haplotype 2212 was associated with AE, and (iii) 
the findings yielded from various models of regression analysis seemed to show that 
rs3806448 and rs2282290 polymorphisms were likely the major causative factors for 
antecubital skin dryness, peripheral blood eosinophil level elevation and cutaneous S. 
aureus colonization. 
Conclusion: 
Our findings support the fact that the AMCase SNPs polymorphisms have a 
significant impact on the susceptibility and pathogenicity of childhood AE. 
Keywords： chitinase (CHIA), acid mammalian chitinase (AMCase), Atopic 
Eczema (AE), eosinophil, scoring atopic dermatitis (SCORAD), Nottingham eczema 
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對照組則從社區招聘。是此硏究首次描述了 AMCase SNPs和AE之間的關係， 
4個SNPs多態性增加了 AE的形成風險，支持了之前的假說。而等位基因頻率 
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1.1 Introduction of Atopic Eczema (AE) 
1.1.1 Definition and classification of AE 
Atopic dermatitis or Atopic Eczema (AE) is a chronically relapsing 
inflammatory skin disease associated with cutaneous hyperreactivity towards 
environmental stimuli (Leung et al, 2003c). Atopic comes from Greek meaning 
"abnormal", while eczema means "eruption". Atopic Eczema is an "itch that rashes". 
The nomenclature committee of European Academy of Allergology and 
Clinical Immunology (EAACI) and the World Allergy Organization (WAO) defined 
atopy as a personal and/or familial tendency in developing the typical symptoms of 
asthma, rhinoconjunctivitis, or eczema (Johansson et al, 2004). The onset of atopy 
usually takes place in adolescence or childhood in response to ordinary exposure to 
allergens, and leads to sensitization, thus, production of immunoglobin E (IgE) 
antibodies. The formation of IgE can be an important manifestation of atopy, albeit, 
not an essential parameter for defining AE. Two major forms of AE have been 
described: (i)"Extrinsic" or allergic type - involves 70-80% of patients and is 
accompanied by elevated serum IgE levels; and (ii)"Intrinsic" or nonallergic type 
without IgE-mediated sensitization affecting 20-30% of patients (Leung et al, 2003c). 
Both forms are associated with eosinophilia, but patients with extrinsic AE produce 
more type-2 T-helper lymphocyte (Th2)-derived cytokines (e.g. interleukin [IL]-4, 
IL-5 and IL-13) than intrinsic AE patients. 
Since IgE-associated mechanism is not a prerequisite in all AE patients and 
objective laboratory diagnostic test is not available, the diagnosis of AE can only be 
made by a constellation of clinical features including pruritus, typical age-related 
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distribution of eczematous lesions and chronicity of the dermatitis (Hanifin et al, 
1980). Hanifin and Rajka defined the most reputable AE diagnostic criteria, which 
clearly set out each clinical state with specific distinctive criteria and features (Table 
1). Thus, these well defined criteria were used in our study. 
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Table 1. Diagnostic criteria for AE (Hanifin et al, 1980) 
Major characteristics: must have at least three: 
1. Pruritus 
2. Typical morphology and distribution 
• Flexural lichenification or linearity in adults and older children 
• Facial and extensor involvement in infants 
3. Chronic or chronically-relapsing course 
4. Personal or family history of atopy (asthma, allergic rhinitis, allergic 
rhinoconj unctivitis, contact urticaria and AE) 
Minor characteristics: should have three or more of: 
1. Xerosis (dryness of skin) 
2. Ichthyosis (especially with palmar hyperlinearity, or keratosis pilaris) 
3. Test of immediate reactivity (type 1) towards skin allergens 
4. Increased serum IgE 
5. Early age of onset 
6. Cutaneous infections by staphylococcal aureus, herpes simplex, molluscum 
contagiosum, warts and other viral infections or impaired cell-mediated 
immunity 
7. Non-specific hand and foot dermatitis 
8. Nipple eczema 
9. Cheilitis 
10. Recurrent conjunctivitis 
11. Dennie-Morgan infraorbital fold 
12. Keratoconus 
13. Anterior subcapsular cataracts 
14. Orbital darkening 
15. Facial pallor or erythema 
16. Pityriasis alba 
17. Anterior neck folds 
18. Itch when sweating 
19. Food intolerance 
20. Course influenced by environmental or emotional factors 
21. Intolerance to wool and lipid solvents, non-absorptive occlusive garment and 
course fabric, as well as wet conditions 
22. Perifollicular accentuation 
23. White dermographism or delayed blanch 
1.1.2 Epidemiology 
Evidence shows an increasing prevalence of AE that exerts a great burden of 
health care expenditure on the society. With a lifetime prevalence of 10-20% in 
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children and 1-3% in adults worldwide (Larsen et al, 1992), AE has become one of 
the most common public health problems today. AE not only presents in early 
infancy or childhood, but it may persist or begin in adulthood (Johansson et al, 2002). 
It is interesting to leam that the occurrence of AE has increased several folds 
over the past three decades in industrialized and developed regions, but it remains 
low in agricultural and developing countries (Taylor et al, 1984). Epidemiological 
data from International Study of Asthma and Allergies in Childhood (ISAAC) 
revealed a 20- to 60-fold global variation in lifetime prevalence of AE (Asher et al, 
2007; Beasley et al, 1998). The data suggest that the increase in prevalence might be 
partly due to increased environmental allergens from industrialization and pollution 
(Diaz-Sanchez, 2000). 
Wide variations of prevalence among different countries have also been 
observed in ethnic groups that share similar genetic background. The difference 
suggests that AE expression of phenotypes can be attributed to environmental factors 
(Williams et al, 1999). Additionally, "western lifestyle" has been identified as a risk 
factor for AE according to the results of comparative studies. The lifestyle includes 
but is not limited to better parental education (Galassi et al, 2006), higher social 
classes (Williams et al, 1994) and increased use of antibiotics (von Mutius, 2000). 
These observations may also account for the high AE prevalence in Hong Kong 
school children with approximately 15-20% (Leung, 1997; Leung et al, 1994), which 
is comparable to other western countries, for instance, UK (20% ) (Kay et al, 1994) 
and USA (10-20%) (Ong et al, 2006). 
The absence of Thl polarizing signals (such as endotoxin) and a decrease in 
the number of infections during early childhood can account for the high level of 
incidence in western urban area. This is because allergic reactions are driven by Th2 
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immune responses, whereas infections induce Thl immune responses (Romagnani, 
2000). As Thl antagonises Th2 development of reactions (or vice versa), the 
lowering of infections - Thl signaling can predispose children to Th2 allergic 
reactions. 
Moreover, several longitudinal studies show that AE often takes place in 
early childhood, and more than 50% of these patients are predisposed to allergic 
rhinitis and asthma (Bergmann et al, 1998; Boguniewicz et al, 2003). As a result, 
these three allergic disorders are recognized as "atopic march" with AE being the 
initiating atopic factor that leads to subsequent development of the others. 
1.1.2.1 The hygiene hypothesis 
Children that have less infections in their infancy and grow up in families 
practicing thorough hygiene are more susceptible to AE (Williams et al, 2004). In 
addition, genetic predisposition contributes significantly to AE susceptibility (Larsen 
et al, 1986; Ong et al, 2006). The above favours the following hypothesis: in utero 
and early years of life environment can lead to AE development in genetically 
susceptible individuals (Novak et al, 2003). It is believed that placental cytokines 
and hormones skew fetal lymphocytes towards Th2 for pregnancy maintenance at the 
maternofetal stage. Whereas, Thl cytokines, such as interferon-gamma (IFN-y), can 
activate cytotoxic cells that damage the placenta (Bjorksten, 2000; Van Bever, 2002). 
Beyond 22 weeks, T-cell starts priming inhalant and nutritive allergens prenatally. 
Thus, IFN-y-dominated Thl responses are induced and Th2 are suppressed upon 
stimulation of infectious agents. The profile switches from Th2 to Thl , so it prohibits 
atopy development. 
Western lifestyle alters the protective microbial microflora in infants resulting 
in the deficit of microbial strains (Kaburagi et al’ 2001). The dominated Th2 immune 
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response induces contraregulatory cytokines, for instance, IL-10 and TGF-P that 
favour further polarization of immunological profile towards Th2 and so atopy 
development. It is supported by probiotic Lactobacillus rhamnosus perinatal and 
postnatal systemic administration leading to 50% risk reduction of AE development 
(Kalliomaki et al, 2001). 
Furthermore, genetic variations of endotoxin and allergens' capacity can also 
increase individual atopic susceptibility, for instance, toll-like receptors' structural 
variants can result in endotoxin under-reactions (Novak et al, 2003). The decrease in 
exposure frequency and quantity of allergens in addition to genetic predisposition 
support the growing prevalence of AE. 
1.2 Pathogenesis and etiology 
The AE pathophysiologic mechanism remains unclear. This is because it 
involves complex interactions between susceptible genes, innate and adaptive 
immunity defectiveness or imbalance, cutaneous infection as well as environmental 
factors (Friedmann et al, 2002; Leung et al, 2003b). 
1.2.1 Biphasic type-l/type-2 T-helper lymphocyte (Thl/Th2) immunological 
responses 
The Thl/Th2 paradigm model is a simplified explanation of immunological 
process (Asadullah et al, 2002a). In this model, Thl and Th2 are differentiated from 
immature CD4+ T-helper lymphocytes (ThO) according to local profile of cytokines. 
The Thl produces mainly INF-y, IL-2 and tumour necrosis factor (TNF)-P, while 
Th2 is characterized by the secretion of IL-4, IL-5, IL-6，IL-9, IL-10 and IL-13 
(Mosmann et al, 1986). They are mutually affected, given that INFy and IL-12 are 
produced by Thl . It is worth noting that INFy and IL-12 favour Thl differentiation 
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and suppress Th2. Thus, an imbalance in the differentiation profile can lead to a 
positive feedback towards the dominance helper cell type. As a result, this supports 
the hygiene hypothesis. 
The skewed Thl/Th2 model in AE results from an overproduction of Th2 and 
suppression of Thl . They favour B cells' IgE production, which in turns activate 
eosinophil and mast cell to release pruritus mediator, histamine (Abramovits, 2005). 
Later investigations propose that other cellular populations also contribute to 
local expression of cytokines (Asadullah et al, 2002b). Broad expression spectrums 
of cytokines complicate our understanding of the immunological processes. 
In the acute phase of AE, IgE takes the central role of the reaction via 
crosslinking with antigens as well as mediating rapid activation and degranulation of 
mast cells, basophils, etc (Friedmann, 2002; Jelinek, 2000). Besides, Thl is 
suggested to involve in the AE development from acute to chronic, exhibiting a 
biphasic T-cell pattern switching from Th2 predominance to a more Thl-like profile 
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Figure 1. The possible mechanism for increased prevalence of allergy as a result of 
Th2 dominance due to reduced exposure of pathogens and pathogen-associated 
molecular patterns (PAMPs) (Baker et al., 2006) 
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1.2.2 Nature and involvements of immunoglobin E (IgE) 
Elevated IgE has long been regarded as the hallmark of atopic disorder 
(Church et al, 1976). It serves as an essential mediator that is allergen-specific and 
hypersensitivity related (Burrows et al, 1989). Latest evidence further proved that an 
elevated total serum IgE level is significantly related to prognosis and severity in 
early infancy (Perkin et al, 2004). 
Dominance of Th2 cytokines can trigger proliferation and differentiation of B 
lymphocytes into antibody secreting plasma cells, which attenuate IgE synthesis 
(Friedmann, 2002; Jelinek, 2000). The synthesized IgE cross-links with high affinity 
IgE Fc receptor (FceR), which is expressed by various cell types, include: mast cells, 
basophils and antigen-presenting cells (APC). Upon binding, granular cells will be 
activated and release bioactive mediators. Besides, the receptor captures and 
internalizes IgE-bound allergens for subsequent processing and presentation. These 
binding and internalization of IgE further aggravates the disorder and sustains 
cutaneous inflammation. 
Figure 2. The differentiation environment of ThO lymphocytes into Thl and Th2 
(Friedmann et al, 2002; Leung et al, 2003d) 
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1.2.3 Microbial colonization 
The fact that applying a combination of topical antibiotics and corticosteroids 
has a higher efficacy than using steroid alone indicated that bacterial infections 
deteriorate the course of AE (Leyden et al, 1977). Staphylococcus aureus was found 
on 90% of the AE skin lesions in contrast to only 5% for the normal people (Cho et 
al, 2001). Furthermore, AE severity was also reported to be correlated with S. aureus 
density, suggesting its role as an irritant with inflammatory potency (Guzik et al, 
2005). 
AE is highly susceptible to S. aureus colonization as the bacteria take the 
advantage of AE skin innate immunity defects. Besides, it expresses an arrary of 
adhesions that bind extracellular matrix components, such as fibrinogen, collagens 
and elastin (Cho et al, 2001; Leung 2003b). S. aureus also binds readily to skin 
lesion dominated by Th2 cytokines, which enhances expression of adhesions and 
downregulation of antimicrobial peptides (Gallo et al, 2002; Ong et al, 2002). 
The bacteria exacerbate and maintain skin inflammation by means of 
superantigen (SAg) production. SAgs activate numerous cell types (Hon et al, 2005), 
inhibit eosinophil and monocyte apoptosis (Bratton et al, 1999; Wedi et al, 2002), 
induce SAgs specific IgE production that correlate with AE severity (Bunikowski et 
al, 1999) and lead to degranulation and histamine secretion. The itch-and-scratch 
vicious circle (Yarwood et al, 2000) is thus sustained. Even worse, SAgs may induce 
drug resistance (Hauk et al, 2000). 
9 
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Figure 3. Antigen is processed and presented by APC via conventional mechanism 
with major histocompatibility complex (MHC) class II molecules. The complex is 
then attached to the specific T-Cell antigen receptor (TCR) (Le Loir et cd, 2003) 
Figure 4 
Figure 4. The activation of non-specific polyclonal T cells through binding the MHC 
class II molecule and then crosslink it with TCR (Le Loir et al, 2003) 
1.2.4 Involvement of cytokines 
Cytokines are rapidly growing superfamilies, with members involving in 
complex interdependent networks of AE development (Homey et al, 2006). 
Chemokines are a class of these superfamilies. They are small secreted signaling 
polypeptides that regulate tissue-specific recruitment and migration of lymphocytes 
(Hijnen et al, 2004). They can be divided into four groups according to cysteine 
residues in their amino acid sequence: CC-, CXC-, CX3C-, and C-chemokines 
(Luster et al, 1998). 
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Chemokines regulate tissues infiltration of inflammatory cells and homing of 
cutaneous-specific lymphocytes with important chemokines, such as thymus and 
activation-regulated chemokine (TARC/CCL17) and cutaneous T cell-attracting 
chemokine (CTACK/CCL27) (Imai et al, 1997). Elevated serum TARC levels lead 
to infiltration of T cells and result in Th2 phenotypes in the skin, which are vital in 
AE pathogenesis (Homey et al, 2000; Kakinuma et al, 2001; Reiss et al, 2001). 
Besides, TARC level is also shown to be significantly correlated with AE severity. 
Whereas, CTACK is constitutively secreted by epidermal keratinocytes, thus, it may 
be involved in basal trafficking of T cells and sustains chronic inflammation 
sustaining under Th2 condition. 
Apart from Th2 specific chemokine, which is proposed to be pivotal and 
specific to AE pathogenesis, many other chemokines have also been shown to be 
associated with AE, including CCLl-5, CCLl l , CCL13, CCL18, CCL20 and CCL26 
(Homey et al, 2006). 
1.2.5 Pruritus inducing neurotrophic factors 
AE is also characterized by distressing pruritus and it results in scratching. 
Persistent scratching disrupts skin barrier mechanically and it also sustain the vicious 
circle of inflammation with itch-and-scratch (Yarwood et al, 2000). 
Histamine was once thought to be the major pruritogenic mediator (Lewis, 
1927). Nevertheless, its role was later found to be overestimated as a small dose of 
histamine failed to induce itching sensation and its receptors' antagonists were 
proved to have low anti-pruritic efficacy (Hanifin et al, 1990). 
Thus, recent studies search for new pruritic agents and there is increasing 
evidence suggesting that neuroimmune mediators take an indispensable role in 
itching or even AE pathogenesis by linking the nervous system with the immune 
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system. Brain-derived neurotrophic factor (BDNF), a member of neurotrophin family, 
was found to be higher in the serum level of AE patients, and it also correlated with 
AE severity (Namura et al, 2007; Raap et al, 2006). BDNF expression is found in 
mast cell, eosinophil, keratinocyte, T-cell, macrophage, etc, suggesting its extensive 
role in AE pathogenesis (Groneberg et al, 2007; Noga et al, 2003; Kerschensteiner et 
al, 1999; Schulte-Herbruggen et al, 2005). The possible modes of action for this 
mediator are: eosinophil apoptosis inhibition, mast cell differential expression, as 
well as induction of proinflammatory cytokines. 
IL-31 is another candidate that is produced predominantly by Th2 cells 
(Dillon et al, 2005). Its transcription is upregulated in skin of AE mimic NC/Nga 
mice. Furthermore, injection of monoclonal IL-31 antibody reduces their scratching 
behaviour. 
The above cytokines and neuropeptides may also account for disease flare 
induced by emotional stress (Leung et al, 2003c). Stress can induce increased 
pruritus and so scratching, resulting from enhanced migration of T lymphocytes as 
well as increased circulation of cutaneous lymphocyte-associated antigen cells, 
mediated by neuropeptides (Akdis et al, 2006; Schmid-Ott et al, 2001). Further 
investigations are called for in the psycho-neuro-immunological aspect in order to 
establish the dynamic equilibrium between the nervous, endocrine and immune 
systems. 
1.2.6 Food allergens, aeroallergens 
AE is characterized by hyperreactivity towards environmental factors that can 
be tolerated among health subjects, nevertheless, trigger and exacerbate disease 
status in susceptible individuals (Leung et al, 2003a). 
Food allergy, which was reported to play an immunopathogenic role in 30-
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50% of moderate to severe AE children, sometimes causes manifestation or even 
anaphylaxis (Hon et al, 2006b; Sampson, 1999). Nevertheless, in most cases, food 
allergy was presented as cutaneous reaction, including erythematous rash, urticaria 
and intense pruritus especially at sites of AE frequently flares up. Double-blind 
placebo-controlled food challenges were used and specific IgE levels were measured 
to access the hypersensitivity. The tests suggested that tree nut, chocolate, peanut, 
soy, wheat, seafood, eggs, cow's milk and citrus fruits are the most frequent allergy-
causing food (Burks, 2003; Leung et al, 2001). Besides, unusual food or substances, 
for instance, complementary and alternative medicine, consumption can result in 
adverse allergy reaction. Neverthesless, dietary practice and preference vary among 
different cultures and individuals, resulting in a wide range of inter-race and inter-
individual food allergy potencies observed (Hon et al, 2006b). 
Aeroallergens, for instance, house dust mites (HDM), weeds, pollens, animal 
danders and moulds, can elicit and exacerbate AE (Leung et al, 2003a). Worsening 
of AE skin lesions as well as erythematous and pruritic rash can result from 
intranasal or bronchial inhalation challenge (Tupker et al, 1996). In general, the 
degree of allergen specific IgE-mediated sensitization is related to the severity of AE 
and acts in a dose-dependent fashion (Schafer et al, 1999). 
1.2.7 Dysregulation of innate immune system 
Apart from adaptive immunity, an increasing evidence suggests that 
dysregulation of innate immunity is one of the most important etiologic factors in AE 
pathogenesis (Wollenberg et al, 2007). Innate system is an immediate but inflexible 
first-line defense against pathogens, with the mode of action being standardized, 
aiming at a complete blockage of pathogenic agents into the host. 
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1.2.7.1 Dysregulation of antimicrobial peptides 
Endogenous antimicrobial peptides play an integral part of innate immunity 
and prevent colonization and infection of bacteria, fungus and virus. These peptides 
are derived from skin keratinocytes. They disrupt and penetrate membrane of target 
microbes as well as interfere intracellular function (Gallo et al, 1998; Ong et al, 
2002). Studies showed that production deficiency of these peptides will result in an 
inadequate host defense against invasion (Mcgirt et al, 2006). About 30% of AE 
patients have bacterial or viral infections on their skin (Ong et al, 2002). Recurrent 
infections of skin lesion can also complicate the course of disease (Leung et al, 1998). 
AE is known to be associated with eczema vaccinatum, which is a skin 
manifestation of viral infection disseminated after vaccinia virus inoculation. This is 
because cathelicidin expression is lower in AE epidermis (Howell et al, 2006). Thus, 
vaccinia virus replication is facilitated. The reduced ability to control vaccinia virus 
replication is also observed in cathelicidin-deficient mice. Besides, the Th2 cytokines 
profile (IL-4 and IL-13) in addition to lowering of type I interferon producing 
plasmacytoid dendritic cells, downregulate virus-stimulated keratinocytes' secretion 
of antimicrobial peptides, thus boosting viral replication. 
1.2.7.2 Skin barrier impairment 
Epidermal barrier dysfunction also plays important roles in AE pathogenesis. 
Loss of barrier integrity increases environmental irritants and allergens penetration 
through epidermis, and predisposes the host to secondary skin infection. The 
exposure can also induce sensitization of antigen-presenting cells, and eventually 
systematic allergic reaction (Wollenberg et al, 2007). 
Furthermore, distorted lipid composition disturbs stratum corneum (SC) in its 
barrier functions. The reduced levels of ceramide can result from increased 
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sphingomyelin deacylase activity or reduced production by keratinocytes. The 
fundamental defects cause xerotic skin, higher permeability of allergens or even 
abnormal keratinization (Leung et al, 2003d; Hara et al, 2000; Fartasch, 1997) 
because ceramide functions as water retaining molecule in extra-cellular space of 
comified envelope (Di Nardo et al, 1998). Thus, its deficiency enhances 
transepidermal water loss (TEWL) and skin dryness (Sator et al, 2003). Both are 
phenotypic characters that present in lesional and non-lesional skin of AE patients 
(Leung et al, 2004). 
Furthermore, distortion of cellular component in addition to structural defects 
increases the susceptibility to AE cutaneous infection. For instance, keratinocyte, 
being a key effector cell, exhibits aberrant functions towards microbial infections. Its 
inappropriate responses against pathogens or antigens are speculated to downregulate 
antimicrobial cascades. In addition, defective superoxide generation (Mrowietz et al, 
1988), chemotaxis (Rogge et al, 1976) and phagocytosis (MI ichaelsson, 1973) are 
illustrated in polymorphonuclear neutrophils. 
The aforementioned mechanisms act together and give rise to cutaneous 
hypersensitivity towards environmental triggers. Lastly, intolerable pruritus induces 
extensive scratching that further breakdowns the skin barrier mechanically. Together 
with inflammatory skin lesion that leads to massive exposure of allergens (Novak et 
al, 2003). 
1.2.8 Genetic predisposition 
AE has a high familial occurrence. Children with one parent having AE have 
30-50% chance of getting it. If both parents are AE patients, the probability can 
increase to 50-80% (Ong et al, 2006). The increment in risk is also noted in 
monozygotic twins (75-85%), who have relatively higher phenotype concordance 
15 
than dizygotic twins (30%) (Larsen et al, 1986). Nevertheless, a high level of genetic 
heterogeneity suggests AE complexity (Novak et al, 2003). 
There are three approaches for identifying the genes for AE pathogenesis: 
linkage mapping, microarray and candidate gene analysis. Linkage mapping and 
microarray do not require any specific hypothesis, instead they identify disease 
causing variants from numerous candidates (Chien et al’ 2007; Morar et al, 2006). 
The mapping uses patterns of inheritance in pedigrees to localize the genetic variants 
with a series of consecutive molecular markers, while microarray simultaneously 
contrasts whole genome expression profiles of case-control study. Nevertheless, they 
are less likely to rule out false positive candidates and type I errors, thus, these 
hypothesis-free approaches reliability are questionable. Apart from the above, 
candidate gene analysis spots disease susceptible genes with existing microbiological 
knowledge. It emphasizes a few interested loci, the evidence of which has suggested 
their potencies in disease pathogenesis. As a result, existing data strengthen the 
rationale, accuracy and effectiveness for the candidate gene analysis, and was 
therefore used in this project. Please refer to Section 2.3 for supporting data for the 
candidate gene selection. 
Although a number of genes have been recognized to be significantly 
associated with AE susceptibility and pathogenesis, only a few were verified by 
association studies and even fewer gene associations have been replicated in more 
than two independent studies (Chien et al, 2007; Morar et al, 2006). The complex 
interaction of gene-gene and gene-environment complicate the inherited disease and 
give enormous difficulties for AE prominent gene identification (Barnes et al, 2001; 
Duffy et al, 1990). 
To summarize, AE involves an intricate interactions of immunological 
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imbalance, microbial colonization, pruritogenic mediators, food and aeroallergens, 
dysregulation of innate immune system as well as genetic predisposition. 
1.3 Assessment of Atopic Eczema (AE) 
1.3.1 AE severity assessment 
There is no definite markers that can reflect AE severity accurately, thus, AE 
diagnosis can only be made clinically (Finlay, 1996). As a result, the presence of 
inter-observer variability hinders therapeutic trials (Kunz et al, 1997). From a clincial 
perspective, a scoring system with optimized guidelines is called for to ensure the 
effectiveness of medical trials. As a result, a simplified standard scheme that scores 
AE according to visual symptoms and disease extent is applied in this study (Kunz et 
al, 1997; Stalder et al, 1993). 
1.3.1.1 Scoring of atopic dermatitis (SCORAD) system 
SCOARD is the most valid, reliable and frequently employed cumulative 
measurement, which was validated in previous clinical trials of AE (Figure 5) 
(Charman et al, 2003). Subjects involved were assessed by one physician only, to 
eliminate inter-observer variability (Kunz et al, 1997). It incorporates both objective 
and subjective criteria of clinical signs, allowing result comparison, systematic 
review production as well as individual study interpretation (Kunz et al, 1997). 
SCORAD is comprised of three parts: (A) - disease extent assessment; (B) - intensity 
evaluation of six clinical signs; and (C) - pruritus and sleep loss visual analog scales 
(Charman et al, 2003). 
Part A is measured by rule of nines and the results will then be recorded 
directly on the affected body sites of the figures, while Part B is measured by six 
grading signs on a scale from 0 to 3 (0=absent, 3=severe): erythema, 
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edema/papulation, oozing/crust, excoriation, lichenification and dryness (Kunz et al, 
1997; Stalder et al, 1993). Part C asks two questions from the patient's perspective, 
concerning pruritus and sleep loss for the past three days with a visual analog scale 
ranging from 0 to 10. The summation of parts A and B produces the Objective 
SCORAD and the addition of subjective symptoms gives rise to the Total SCORAD. 
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Figure 5. Scoring of atopic dermatitis (SCORAD) index diagnosis worksheet for 
accessing present AE severity of children above two years (Charman et al, 2003) 
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1.3.1.2 Nottingham eczema severity score (NESS) 
NESS was developed for a community-based epidemiological research that 
aimed at assessing AE severity from a whole patient perspective (Figure 6) (Rajka et 
al, 1989). It is the most important scheme for evaluating AE severity over the 
preceding 12 months. 
This questionnaire is simple, quick to use and has been validated (Sturgill et 
al, 2004; Hon et al, 2003). Its importance lies in the incorporation of chronicity 
element that helps to determine disease activity, since AE is a fluctuating clinical 
course of disorder (Emerson et al, 2000). NESS is an interviewer-administrated 
questionnaire which consists of three elements: clinical course chronicity, disease 
intensity over last 12 months, as well as present extent of AE. The higher the score 
indicates more severe disease and reflects longer duration of symptoms. 
It should be noted that the extent of AE is assessed differently from 
SCOARD since it is filled in by the parents, who are usually not a medical 
professional. Thus, the parents are instructed to tick the affected boxes on the surface 
diagram only in case the affected area is more than 2 cm (about the size of Hong 
Kong 50 cents coin). As a result, the matter becomes less complicated and minimizes 
the likelihood of inter-observer error. (Emerson et al, 2000). 
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1 .在過去的 1 2個月，你子女皮膚滋療情沉總共維持了多久？ 
猜選擇一個"V" 
a . 少 於 6 星 期 口 
b. 6星期至少於3個月 口 
C. 3個月至少於6個月 口 
d. 6姻月至少於9姻月 口 
e. 9個月或以上 口 
2.在過去的12個月內，你子女因滿療引致皮膚痕疼或抓疼而影麥睡敢的次數？ 
猜選揮一個"V" 
a .沒有 口 
b . 平均每星期 1晚， • 
C .平均每星期 2或 3晚 口 
d . 平均每星期 4 或 5 晚 口 
e . 平均每星期 6晚或以上 口 
3 .靖在 2 § ^ _濕療範面內域上一個 " t 
§ Q 
普晉 
M 前面 W U 後 面 
0 V3 A G 
堪裔人(關f?© : _ _ _ L _ J 
日期： 
Figure 6. Nottingham eczema severity score (NESS) self-administrated worksheet 
for accessing 12-months AE severity in Chinese (Rajka et al, 1989) 
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1.3.2 Dermatological parameter - skin hydration (SH) and transepidermal 
water loss (TEWL) 
AE is characterized by dry and non-intact skin, with occasional flexural 
involvement. Thus, skin hydration (SH, arbitrary unit [a.u.]) and TEWL (g/m^/h) are 
important parameters that identify AE objectively by measuring conductivity and 
integrity of the barrier (Hon et al, 2008). These biophysical parameters are measured 
with a standardized method that was validated by our team. The pervious study 
showed a significant correlation of these parameters with SCORAD (SH:r=-
0.553,p<0.001; TEWL:r=0.596,j!?<0.001) and NESS (SH:r=-0.494,j9<0.001; 
TEWL:r=0.430,p=0.004) (Hon et al, 2008). 
The bioengineering assessment only takes less than two minutes for each 
patient and is very convenient to measure. Besides, the non-invasive measurement of 
SH is obviously more objective than SCORAD that categorizes skin dryness into 0-3 
(normal to severe dryness) (Stalder et al, 1993). The skin barrier function 
impairments can be measured from active AE normal skin but not on the skin which 
is completely healed from AE. The latter implies that secondary or subclinical 
eczematous changes have occurred (Sakurai et al, 2002). These parameters help the 
understanding of AE pathophysiology and possible chitinase (CHIA) polymorphic 
effects on skin nature. 
1.4 Chitinase (CHIA) 
1.4.1 Chitin and CHIA 
Chitin is the second most abundant biopolymer, following cellulose (Debono 
et al’ 1994). The cross-linked polysaccharide is tough and is extensively found in 
pathogens, for instance, fungi cell wall, microfilaria! sheath and helminth egg. Thus, 
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it functions as an important target molecule for host recognition and defense in plants 
and higher animals (Singh et al, 2007). 
Chitin can be degraded by a group of species and evolutionary conserved 
enzymes, CHIAs (Gianfrancesco et al, 2004). Evidence shows that CHIA protects the 
host by degrading the key structural element of pathogens (Choi et al, 2001). In 
addition, some CM/4-like family proteins lack enzymatic activity. Their mode of 
actions may be similar to mannose-binding lectin, which functions as pathogen 
recognition and activation of host defenses (Holmskov et al, 2003). 
It is believed that CHIA should not have any function in human since 
complete absence of endogenous chitin was assumed. Nevertheless, CHIA and 
CHIA-likQ proteins have been identified in mammal,s genomes recently (Bussink et 
al, 2007). The first identified enzyme in this family was chitotriosidasem, which was 
found to be distinctly higher in plasma of patients with Gaucher disease (Hollak et al, 
1994). After that, another member, acid mammalian chitinase {AMCase) was also 
found (Boot et al, 2001). As its name implies, the enzyme works optimally in acidic 
pH (pH 2) conditions. 
1.4.2 Association of acid mammalian chitinase {AMCase) with asthma 
AMCase is a member of 18-glycosyl hydrolases family. It was found to play a 
crucial role in the development of murine asthma (Zhu et al, 2004). This molecule 
was observed to be highly expressed in the lungs of ovalbumin-sensitized mice. 
Besides, inhibition of AMCase attenuates Th2 inflammation, airway eosinophilia and 
bronchial hyperreactivity in response to ovalbumin challenge (Homer et al, 2006). 
Similar results with chitinase homologous proteins were perceived in different 
models (Webb et al, 2001; Zimmermann et al, 2004). Furthermore, it was found that 
the CHIA family is secreted in tissue specific manner with AMCase highly expressed 
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in lungs of asthmatic patients but not in healthy subjects. (Boot et al, 2001; Chupp et 
al, 2007; Zhu et al, 2004). The chitin-induced eosinophilic lung inflammation was 
also found to be markedly attenuated in AMCase over expressed mice (Reese et al, 
2007). AMCase obviously plays a critical role in causing asthmatic airway 
inflammation. 
1.4.3 Hygiene hypothesis implies: acid mammalian chitinase {AMCase) and 
allergy relationship 
Parasitic infection shares a similar Th2 profile of cytokines as asthmatic 
inflammation (McKenzie, 2001). Nevertheless, microbial burden reductions can 
result in host inflammation attenuation and one of the evidence is that AMCase is 
involved in four proinflammatory signaling (Zhu et al, 2004). In addition, oral and 
intranasal administration of chitin to mice before and during allergen immunization 
reduces the allergic hypersensitivity compared with the mice not given chitin and 
they have lower IgE and eosinophil levels (Shibata et al, 2000; Strong et al, 2002). 
These findings suggest a possible involvement of AMCase in allergy pathogenesis 
under the context of the hygiene hypothesis (Von Hertzen et al, 2004). 
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CHAPTER 2 
Hypothesis and Objectives 
2.1 Hypothesis - based on the chitinase (CHIA) involvement in canine Atopic 
Eczema (AE) 
The role of chitinases (CHIAs) in human allergic skin diseases has not been 
studied to date. Only a study in dogs suggested that CHIA was involved in Atopic 
Eczema (AE) pathogenesis (McCall et al, 2001). The IgE antibody which was 
specific to two insect CHIA homologous proteins was found in the serum of the dogs 
sensitized with the Dermatophagoides farinae (a type of house dust mite) extracts. 
Intradermal testing with the purified insect CHIA homologous proteins yielded 
positive reactions in sensitized atopic dogs but not in normal dogs. Thus, these 
findings seemed to support that CHIA is a major allergen for canine AE. 
2.2 Hypothesis 
Based on the chitinase (CHIA) involvement in canine Atopic Eczema (AE), 
we hypothesized that CHIA may also play a crucial role in the pathogenesis of 
human AE and the genetic polymorphism of acid mammalian chitinase {AMCase) is 
associated with childhood AE. 
2.3 Objective - based on acid mammalian chitinase (AMCase) single 
nucleotide polymorphism (SNPs) in asthma susceptibility 
Two studies supported the important role of acid mammalian chitinase 
{AMCase) in the modulation of asthma susceptibility (Bierbaum et al, 2005). In these 
studies, a few dozens of AMCase single-nucleotide polymorphisms (SNPs) were 
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genotyped and the statistical association between the AMCase genotype and asthma 
was found to be highly significant. 
Because of the close relationship between Atopic Eczema (AE) and asthma, it 
is logical to suspect that a close link between acid mammalian chitinase {AMCase) 
genotype and asthma also exists in the case of AE. However, up till now, the 
association between AMCase polymorphism and eczema has not yet been studied. 
This formulates the aim of our study. 
Studies on asthma suggested that three SNPs were significantly associated 
with asthma. These SNPs include: i) rs3806448 (尸aduit=0.00001’ OR=1.72; 
尸paediatric=0.0002, OR=1.95), ii) rs3818822 (Ppaediatric=0.0003, OR=1.70) and iii) 
rs2282290 (Paduit=0.00009, OR=1.60; Ppaediatric=0.00003, OR=2.05) (Bierbaum et al, 
2005; Chatterjee et al, 2008); and they were targeted in this AE genetic association 
study. In addition, the SNP rs3806446 was also included as it is linked to rs3806448 
in the same polymerase chain reaction (PGR) product and it can be conveniently 
analyzed. 
Furthermore, the selected SNPs were scattered at different regulatory regions 
of the AMCase gene. This allows speculations of the possible etiologic mechanism of 
Atopic Eczema (AE). For example, rs3806448 and rs3 806446 are located at the 
promoter region, thus, different genotypes of them can have diverse effects on the 
transcription and expression of AMCase. In addition, rs3 806448 was found to be in 
complete linkage disequilibrium (LD) with a few other promoter SNPs that show 
potential binding sites of transcription factors. For rs2282290, it is at the 5'UTR 
region which is a potential enhancer or silencer binding site. The last candidate of 
this study is rs3818822, which is at the 5' UTR region and in complete LD with 
some other regulatory SNPs. 
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2.4 Objectives 
This study investigates the association between four SNPs in acid 
mammalian chitinase (AMCase) gene and the Atopic Eczema (AE) in Hong Kong 
Chinese children. Specifically, it aimed to (i) determine the allele frequency of 
AMCase SNPs; and (ii) investigate whether the selected SNPs are associated with 




3.1 Recruitment of cases and controls 
In order to obtain a statistical power of 0.80 with 95% confidence and to have 
1% difference between the AE case and the control group, 200 subjects should be 
recruited in each group. 
A cohort of 218 unrelated, southern Chinese children aged 18 years or below 
was recruited from the paediatric dermatology outpatient clinic of the Prince of 
Wales Hospital in Hong Kong. The diagnosis of AE was carried out by a single 
physician based on Hanifin and Rajka criteria (Hanifin et al, 1980). Subjects were 
excluded from this study if (a) they suffered from concomitant inflammatory 
dermatitis or showed symptoms of coexisting airway allergies; (b) the patients cannot 
provide important information regarding the course of disease; and (c) the subjects 
suffered from obvious systematic disorders such as malignancy. 
A total of 192 school children, who had participated in the local Phase 3 
ISAAC (ISAAC, 1998)，were recruited as healthy Chinese controls. These control 
subjects had neither physician-diagnosed allergy nor required drug treatment at the 
time of study. 
Clinical Research Ethics Committee of The Chinese University of Hong 
Kong had approved this study. Informed written consents were obtained from all 
participants and their parents or guardians prior to samples collection. 
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3.2 Assessment of clinical parameters 
3.2.1 Scoring of atopic dermatitis (SCORAD) system 
All patients were assessed by the same physician so as to avoid interpersonal 
variability. The maximum total score was 103 and the score was formulated as 
follows: 20 for disease extent, 63 on clinical signs, 20 for the subjective symptoms of 
pruritus and sleep loss (Charman et al, 2003). 
Objective SCORAD (disease extents and intensity of six clinical signs) as 
well as Total SCORAD (Objective SCORAD plus subjective symptoms) were 
assessed and recorded. The Objective SCORAD categorized subjects' AE severity 
into mild (<15)，moderate ( 1 5 ^ 0 ) and severe (>40). 
3.2.2 Nottingham eczema severity score (NESS) 
All parameters shared equal weight. Each parameter carried a score of 1-5. 
Children were graded into mild (score 3-8)，moderate (score 9-11) and severe (score 
12-15) (Figure 6). 
3.2.3 Dermatologic parameters 
3.2.3.1 Cutaneous bacterial colonization 
Staphylococcus aureus infection and colonization are commonly observed in 
the Atopic Eczema (AE) patients. The infections are the result of extensive lesion 
and oozing (Hon et al, 2005). To assess the bacterial colonization severity, swabs 
were used to obtain sample from the skin lesion of the patients. The sample obtaining 
process was standardized as five seconds rubbing of a piece of swab (COPAN 
Innovation, Italy) on the most severely affected lesion. Patients were excluded from 
the study if they suffered from other inflammatory dermatitis or had been treated 
with systemic and topical antibiotics four weeks prior to the assessment. Standard 
laboratory techniques were then carried out for cultivating swabs' bacteria. 
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Bacteriology results were classified as no growth, scanty ( � l O * colony-forming units 
per mL), moderate (lO^ to 10^) or heavy (>10^). Bacteria, other than S. aureus, were 
not investigated (Hon et al, 2005). 
3.2.3.2 Skin hydration (SH) and transepidermal water loss (TEWL) 
Patients were allowed to rest in an air-conditioned waiting area before 
entering the consultation room, in which temperature and humidity were strictly 
controlled in a narrow range. After sitting in the room for 20-30 minutes for 
acclimation, SH (arbitrary unit [a.u.]) and TEWL (g/m2/h) were measured with 
Mobile Skin Center MSG 100 equipped with a corneometer CM 825 and a 
Tewameter TM 210 probes (Courage & Khazaka electronic GmbH, Cologne, 
Germany). The assessment was performed on the right forearm of the patients at 
three sites: i) antecubital fossa; ii) 2cm distal antecubital flexure; and iii) mid-
forearm following the manufacturer's instructions (Hon et al, 2008). Measurements 
were performed on unaffected skin only. All lesions, oozing or infected areas on the 
assessment sites were avoided by placing the probes slightly sideway. (Kim et al, 
2006). It was because affected the skin regions can influence skin condition 
assessment, for example, erythema elevates TEWL and lichenification reduces SH. 
Subjects who applied emollients within three hours prior to assessment were 
excluded. 
3.3 Peripheral blood collection and genomic deoxyribonucleic acid (DNA) 
extraction 
A total of five millilitres (ml) peripheral blood was drawn from each subject. 
The blood drawn was used as follows: 3 ml for the genotyping of the four AMCase 
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SNPs, 1 ml for the serum total IgE level determination, and 1 ml for the complete 
blood count. 
EDTA-anticoagulated venous blood contained in Vacuette® tube (Greiner 
Bio-One, Baldwin, MD) was centrifuged at 2000g for 10 minutes at 4°C. Plasma was 
then removed and 3 volumes of red blood cell lysis buffer (10 mM KHCO3, 155 mM 
NH4CI, 0.1 mM EDTA, pH 8.0) was added to 1 volume of cell. After incubation of 
the solution on ice for 15 minutes for the lysis of erythrocytes, the solution was 
centrifuged again at the same condition as above. Supernatant was discarded and 
pellet was mixed with lysis buffer. The mixture was centrifuged again to harvest the 
leukocytes which were in the pellet. DNA was then extracted from the white cell 
pellet with Qiagen DNeasy Blood and Tissue kit (Qiagen, Venlo, NLD) and stored at 
-80°C until analysis. 
3.4 Acid mammalian chitinase (AMCase) polymorphism genotyping 
3.4.1 PCR amplification of AMCase gene 
Four AMCase SNPs were genotyped: rs3806448, rs3806446, rs3818822 and 
rs2282290. Genotyping was done by first amplifying the three sites of interest with 
three specific pairs of primers (Invitrogen, Carlsbad, CA) using PCR. The four SNPs 
were amplified in three PCR products using the thermo cycler PTC-200 (MJ 
Research, Massachusetts, USA). The primer sequences and the annealing conditions 
used in the PCR were listed in Table 2. 
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Table 2. PGR primers sequences and annealing conditions for AMCase SNPs 
genotyping 
SNP ^ P ^ r I Annealing I Product 
condition size / bp 
rs3806448’ Forward: 5'-TCT GCC ATC GCT TCT GTC TCT GA-3' ^qoq^ 
rs3 806446 Reverse : 5'-TTC CTT CCC TTT GCA CCC ATT TA-3' 45 sec 
Forward: 5'-GAA GTT TTC AGT AGG GGA GG-3' ccop 
rs3818822 � 262 
leverse : 5'-GAT CAC ATG GGG CTA ACT TG-3' 州 sec 
Forward: 5’-CGG GAA CGG GAG CGG GAG TA-3’ �� 
rs2282290 , ’ 890 
leverse : 5,-CGA GCT GCA AAT TCT GAG GTG TGA TAA-3’ ‘ 麵 
3.4.1.1 List of PGR reagents 
The reagents used in the PGR reactions were summarized in Table 3. 
AmpliTaq Gold® DNA polymerase used was 5U/|al, while the reaction buffer and 
magnesium chloride stocks required a 10-fold dilution (Applied Biosystems, Foster 
City, CA). The buffer consisted of 500 mM KCl and 100 mM Tris-HCl at pH 8.3, 
which enabled the modified enzyme to perform precise and 'hot start' amplification. 
Table 3. PGR amplification constituents 
Constituents Volume (^il) 
AmpliTaq Gold® DNA polymerase 0.2 
15 |uiM Forward primer 0.25 
15 |jM Backward primer 0.25 
10 mM dNTP mix (PGR grade) — 0.3 
1 Ox PGR Gold PGR buffer “ 3 
1 Ox PGR Gold MgCb 3 
cDNA (10 ng/|al) 6 
MilliQ autoclaved H2O — 17 
Total ^ 
Forward and backward primers (Invitrogen, Carlsbad, CA) were reconstituted 
from lyophilized powder with milliQ autoclaved water to 300 ^iM as stock and 15 
\xM for working in -20°C for storage. 
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Deoxynucleotide triphosphate (dNTP) set (Roche, Indianapolis, IN) was a 
mixture o fdATP, dTTP, dCTP and dGTP. Each nucleotide was dissolved in 100 mM 
sodium salt solution at pH 8.3. In addition, 20 |il of these nucleotides (25 |imol) were 
added and diluted in 120 \i\ MilliQ water, resulting in a 10 mM mixture. 
3.4.1.2 Electrophoresis reagents 
lOx DNA loading buffer was prepared with 0.25% (w/v) bromophenol blue 
(Amersham Biosciences, Piscataway, NJ)，0.25% (w/v) xylene cyanol FF (ICN 
BioMedicals Inc, Irvine, CA), and 67% (v/v) glycerol (Amersham Biosciences, 
Piscataway, NJ) in autoclaved MilliQ water. 
Four \x\ of DNA 100-bp marker (50 ng/jil) (Invitrogen, Carlsbad, CA) was 
used in each agarose gel to mark the size of cDNA from 100 to 1,500 bp. Its working 
solution was prepared by mixing the stock, lOx loading buffer and TE buffer (10 mM 
Tris-HCl, 0.1 mM EDTA，pH 8.0) in a volume ratio of 5:17:78. 
3.4.2 Restriction fragment length polymorphism (RFLP) analysis of AMCase 
and confirmation with direct sequencing 
Half of the PCR products (15 |il) were used for initial screening with three 
allele-specific restriction enzymes. (New England Biolabs, Herts, UK). The type and 
the amount of enzyme used were listed in Table 4. The restriction pattern was 
analyzed using agarose gel electrophoresis. 
Table 4. Types of restriction enzymes and number of units used for each SNP 




rs3818822 Acul 3 
rs2282290 XmnI 3 
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SNPs polymorphisms of 5% randomly selected subjects were further 
confirmed independently by cycle sequencing with BigDye Terminator Cycle 
sequencing kit using ABI-3130 Genetic Analyzer (Applied Biosystems, Foster City, 
CA). 
3.5 Statistical analysis 
Data were reported as proportion (%) or mean value with standard deviation 
(SD) unless otherwise stated. Chi-square or fisher exact test was used to compare 
categorical variables. All SNPs were evaluated for Hardy-Weinberg Equilibrium 
(HWE) by exact test. Their allele frequencies were compared between cases and 
controls by Pearson x2 test. 
Haplotype frequencies were estimated with Max-Delbruck-Centrum (MDC) 
(http://www.bioinf.mdc-berlin.de/projects/hap/intro.html). Linear and binary 
regressions were performed incorporating sex, age and asthma as covariates for 
adjustment. Three models were used in regression analysis: (i) Codominant model, 
which assumed that the risk is increased with the copy of risk allele(s), A/a, 
employing phenotype of homozygous dominant genotype (AA) as the reference (i.e. 
phenotypic expression: (l)AA[ref.] v.s. Aa and (2)AA[ref.] v.s. aa); (ii) Additive 
model, which justified that phenotype of Aa is the midway between that of AA and 
aa, using AA as the reference (i.e. phenotypic expression: AA[ref.]>Aa>aa); and (iii) 
Recessive model, which compared phenotype of AA or Aa with that of aa, assuming 
that a phenotypic expression can only be observed in homozygous recessive 
genotype, using aa phenotypic expression as the reference (i.e. phenotypic expression: 
aa[ref.]>Aa or AA). 
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All statistical analyses in the genetic association study were performed using 
SPSS for Windows v. 13 (Chicago, IL，USA). The comparisons were two-tailed and p 
values of smaller than 0.05 were considered to be significant. 
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CHAPTER 4 
Results and Data Analysis 
4.1 Results 
4.1.1 Demographic data of cases and controls 
A total of 218 (119 boys and 99 girls) unrelated southern Chinese children 
with AE were recruited. The mean 士 S.D. age of the patients enrolled was 10.7 士 4.4 
years. According to SCOARD, the patients could be categorized into three groups in 
relation to AE severity: mild (n=28; 12.8%), moderate (n=93; 42.7%) and severe 
(n=91; 41.7%). Besides, 143 of these AE patients had co-existing allergic rhinitis, 
while 77 had history of asthma or hyperactive airway disease. 
One hundred and ninety-two (96 boys and 96 girls) ethnic-matched non-
allergic controls, with age 15.4 士 1.8 years were studied. The controls were mainly 
recruited from three local colleges. They were deliberately chosen from secondary 
schools to ensure that they did not have any atopy in their childhood. Table 5 
describes the demographics data for cases and controls. 
Table 5. Demographic profile of AE patients and controls cohorts (mean 士 S.D.) 
AE cases Control 
Recruitment Source Outpatient clinic Community 
Subject recruited i n T ^ 
Mean age (yr) 10.7 ±4 .4 15.4 士 1.8 
Sex ratio (M:F) 0.55 : 0.45 0.50 : 0.50 
Serum IgE level (lU/ml) 6012 ± 10361 225 ± 750 
Serum eosinophil count 0.78 士 0.57 N.A. 
Serum eosinophil count / Vo 9.6 士 5.4 
Total SCORAD 47.7 ±20.1 N.A. 
Objective SCORAD 36.3 ± 18.1 
NESS 11.1 士 2.9 N.A. 
36 
4.1.2 PCR amplification and RFLP analysis of AMCase gene 
AMCase was successfully amplified by PCR with three predicted fragments 
of 574 bases pair (bp) (rs3806448 & rs3806446), 262 bp (rs3818822) and 890 bp 
(rs2282290). A 1% agarose gel electrophoresis photo illustrates their presence in 
Figure 7. 
100 bp 
ladder (i) (ii) (iii) (iv) (v) (vi) 
_ b p 
I.::::誓 
‘ ^ ~ 262 bp 
iBiii. 
Figure 7. A 1% agarose gel electrophoresis of the three PCR products: (i & ii) 
rs2282290, (iii & iv) rs3806448 and rs3806446, (v & vi) rs3818822 
The fragments of( i ) rs3806448 and rs3806446, (ii) rs3818822 as well as (iii) 
rs2282290 were then cleaved by three specific restriction enzymes: (i) Taq°I, (ii) 
Acul and (iii) XmnI, respectively, at 37°C overnight. In case of rs3818822 and 
rs2282290 PCR products, the only restriction recognized cutting sites were at the 
polymorphic SNPs. Thus, only three restriction fragment patterns could be observed 
upon 3% agarose gel electrophoresis, for instance, rs2282290 SNP: (i) homozygous 
major genotype, AA could be cleaved into two fragments - 564 bp and 326 bp; (ii) 
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homozygous minor - G G remained the PCR product intact and was shown as 890 bp 
in gel photo; (iii) heterozygous AG allowed XmnI cleaving one DNA strains only, 
result in both patterns - combination of three bands. Representative RFLP results of 
rs2282290 are illustrated in Figure 8. 
lOObp 
ladder � (“) ( " 0 (iv) � (vi) 
8 9 � b p 
11 M l ^ g < ~ 564 bp 
Figure 8. 3% agarose gel electrophoresis of rs2282290 PCR product cleaved by the 
restriction enzyme XmnI: (i & iv) homozygous GG, (ii & iii) homozygous AA, (v & 
vi) heterozygous AG 
Similar RFLP results were obtained for rs3818822 PCR products that 
underwent Acul cutting. However, instead of the major allele, minor allele could be 
cut only. As a result: (i) 92 bp and 170 bp could be seen in case of homozygous 
minor genotypes, AA; (ii) 262 bp PCR product remained intact for homozygous 




ladder (0 (“) (iii) O ) (v) 
•p HHHI 
^^^^^ .^ ir：：：：： 
,.‘ 92 bp 
Figure 9. 3% agarose gel electrophoresis of rs3818822 PGR product cleaved by the 
restriction enzyme Acul: (i & ii) homozygous GG，(iii & iv) heterozygous GA, (v) 
homozygous AA 
RFLP results for rs3806448 and rs3806446 PGR products were more 
complicated. Although the only restriction recognized sites were still positioned at 
the SNPs, there were two SNPs on a single PGR product. Taq"I could cut 
simultaneously both available SNPs' alleles and attain complete digestion for both 
sites in a single reaction. Twelve units (3 times that of the others used) of Taq"I was 
used for the RFLP reactions. Although there were 10 possible combinations of the 
bands, only five patterns/genotypes could be observed as shown in Figure 10. The 
likely reason for this observation was that the two SNPs were only 85 bp apart and 
linked, leading to the absence of some genotypes. 
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lOObp 
ladder � （ii) (iH) (iv) (v) 
IMP 國 • • 
^ ^ ^ ^ H H ^ _ 3 8 4 bp 
！<—190 bp 
m 
Figure 10. 3% agarose gel electrophoresis of rs3806448 and 3806446 PGR product 
cleaved by the restriction enzyme Taq"I: 
(i) rs3806448 - TT & rs3806446 - TT; 
(ii) rs3806448 - TC & rs3806446 - TT; 
(iii) rs3806448 — CC & rs3806446 - TT; 
(iv) rs3806448 — TT & rs3806446 - CT; 
(v) rs3806448 — TT & rs3806446 - CC; 
4.1.3 PGR cycle sequencing of the PGR fragments 
Cycle or direct sequencing of the PGR products confirmed the RFLP results 
independently in 5% randomly selected subjects. The electrophoreograms of the 
SNPs illustrating their sequences are shown in Figures 11-12. 
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m m s t 
Figure 11. Sequencing analysis of fragments with rs3806448 G/A nucleotide 
dimorphism highlighted 
j n n 1 r s 3 8 0 6 4 4 6 T ^ 
W \\ 
kimm 
I r s 3 8 0 6 4 4 6 C C ~ 
MlklMM 
Figure 12. Sequencing analysis of fragments with rs3 806446 T/C nucleotide 
dimorphism highlighted 
4.2 Data analysis 
4.2.1 Data overview 
The RFLP results were unambiguously assigned to the AE cases and the 
controls cohorts. It was found that the distribution of all AMCase SNPs except for 
rs3806448 control group (p=0.028) was in HWE (Table 7). Besides, differences were 
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also noted when comparing minor allele frequency (MAF) of our controls with that 
of the HapMap Han Chinese (Table 6). 
Table 6. Comparison between MAF of SNPs in our controls and those published in 
the HapMap database 
Ref. / HapMap published 
Polymorphic MAF - — 
Marker Alt. allele Detected Han Chinese Japanese European African 
rs3806448 — T / C " 0.142 0.333 0.227 ^517 ^ 5 3 
1 ^ 0 6 4 4 6 C / T 0.186 0.367 0.344 0.558 0.725 
7 ^ 1 8 8 2 2 G / A 00^3 0.144 0.056 0.133 0.217 
& 8 2 2 9 0 A / G 0.342 |o.l78 |o.386 |Q.433 0.283 “ 
Table 7. Genotypes distribution of four AMCase SNPs polymorphisms 
SNP I Samples iGenotype (no.) Allele frequency p value ^ d s ratio |95% C.I. IHWE 
TT(133) — R 
严 。 i Q � T C (73) T=339 C=97 0.894 (n=218) 
rs3806448 。。 (⑵ 0.033 1.486 1.04-2.12 
TT(130) 
� n 二 1) TC (62) T=322 C=62 0.028 
CC (0) 
cc(in) 
5=218) CT(79) 0 3 1 3 T=123 0.298 
rs3806446 二 = 0.019 1.470 1.07-2.03 
？ C T ( 6 3 ) C=303 T=81 0.981 
TT (9) 
(^^218) GA(49) G=383 A=53 0.741 
rs3818822 么么 ( � ) “ � 0.217 1.338 0.86-2.09 
GCJ (1 J O ) 
� : = 二 GA(36) G=348 A=36 0.358 
AA (0) 
；;; AA(96) 
^ ^ 2 1 8 ) AG (95) A=287 G=149 0.898 
rs2282290 0.190 1.221 0.92-1.62 
AA (64) 
二 总 AG (107) A=235 G=149 0.056 
I | g G (21) 
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4.2.2 Genotypes distribution of AMCase polymorphisms 
4.2.2.1 Allele frequency comparison of AMCase single nucleotide 
polymorphism(s) (SNPs) by chi-square 
The four SNPs for the studied groups are shown in Table 7. The allele 
frequency distribution of the patients and controls were significantly different for 
rs3806448 (p=0.033; Odds ratio, OR=1.486) and rs3806446 (p=0.019, 0 R = 1.470). 
However, the differences were insignificant for the other SNPs. 
Graphical representation of the distribution of four genotypes of our SNPs is 
shown in Figure 13. In general, the increase in homozygous recessive and 
heterozygous genotypes was accompanied by a decrease in homozygous dominant 
genotype. As a result, MAF of the SNPs increased. 
C u e I Conlrol Case I Conlrol 
CooUol ^ Conlrol ^ 
0 I 2 0 1 2 0 丨 2 0 丨 i 
r 13806448 rii380M48 rs380M46 r»3806446 
Case / Control Case / Control 
Contfol ConUo\ AD 
m - 加-
'iLIIJ'IiJL 
0 I 2 0 I 2 0 1 2 0 I 2 
ri22g22W r«2282290 t»3818827. r>3818822 
Figure 13. Graphical representation of four AMCase SNPs polymorphisms 
Key: (i) 0 - homozygous major genotype; (ii) 1 - heterozygous genotype; 
(iii) 2 - homozygous minor genotype 
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4.2.2.2 Allele frequency comparison of AMCase SNPs by logistic regression 
analysis 
In addition to the distribution analysis of allele frequencies via chi-square, the 
four SNPs were also inputted to different models for regression analysis (Table 8). In 
order to minimize the manifestation by other allergy, asthma was inputted and 
categorized in the models as the covariate. The input should rule out the possibility 
of false positive result by analysing the effect of asthma on AMCase SNPs 
polymorphisms. 
Table 8. Significant parameters of binary logistic regression analysis among disease 
status with individual SNPs polymorphisms in different models 
Dependent 广 . • Polymorphism AE case: „ , ^ , , 
• Li Covariates . . ^ / o / � ‘ , P value Odds ratio variable (AE cases / %) Control 
。。八，』，。CC (5.0) 1 1 : 1 Recessive model 
rs3 806448 
TC + TT (94.9) 207 : 191 0.001 0.019 
训 8822 AA (0.9) / Recessive model 
^ GA + GG (99.17/ 0.999 [l.837xl0 " 
rs3 806448 Codominant model 
rs3806448(l)/ / 0.931 |Q.973 “ 
AE / Control rs3806448(2) 二？二 ) 0.001 52.492 
V-^ V^  1 ^ • y J J 1 1 • 1 
rs3 806446 Codominant model 
rs3806446(l)/ / 0.726 l l . l lS 
r s3806446(^ / / ~ 0.067 2.959 — 
rs3818822 Codominant model 
rs3818822(l)/ / —0.932 |l.Q31 
| rs3818822(2)|/ |/ |Q.999 丨54670529694 
The comparison of case-control distribution of alleles in the recessive model 
provided significant evidence to show that only rs3806448 (p=0.001) was the 
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causative factor of AE. The ratio of AE case number against control number 
illustrated an increase in risk in homozygous recessive genotype. This was because 
the ratio was closed to one (207:191) only for the genotypes with at least one major 
allele. The ratio rose in the homozygous minor genotype, giving the AE number of 
cases ten folds higher than that of the controls (11:1). The odds ratio (OR=0.019) 
was a lot smaller than one and this reconfirmed the strong protective effect of 
rs3806448 major allele. 
Moreover, the co-dominant model was studied. It produced a similar result. 
Nevertheless, significant difference was only presented between homozygous 
dominant and homozygous recessive genotypes: rs3806448 (2) (p=0.001) only. A 
large odds ratio (OR=52.492) confirmed the difference between two homozygous 
genotypes in comparison. 
A marginal insignificant p-valuQ was observed in rs3806446 (2) (p=0.067) 
comparison with a fair odds ratio (OR=2.959). Abnormal odds ratio 
(OR=54670529694 & 1.837xl0-n) was obtained when rs3818822 served as the 
covariate in case-control comparison. 
4.2.3 Haplotype frequency estimation via maximum likelihood algorithm 
Max-Delbruck-Centrum (MDC) estimation allowed the generation of 
haplotype frequencies with all SNP genotypes. The corresponding number of 
subjects possessing each haplotype could be calculated. Chi-square was then used to 
compare the p value and odds ratio between groups and relation information is 
presented in Table 9. There were eight combinations of haplotypes for the studied 
subjects, and one of them was found significantly different between the two groups. 
The haplotype was 2212 (p=0.036) with 1 and 2 to be denoted as major and minor 
alleles, respectively. A bar chart of the haplotype frequencies is plotted in Figure 14. 
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Table 9. Maximum likelihood algorithm estimated haplotype frequency 
TT 1 ^ AE Control AE Control „ , , ? . Haplotype „ « Odds ratio p value frequency frequency cases no. ^ 
n i l 0.405 0.3815 88.29 73.248 Reference Reference 
1112 0.2778 a3646 60.5604 70.0032~~0.72 0.169 “ 
2211 0.1118 0.1092 3 .3724 20.9664 0.95 0.875 
2221 0.0823 0.0493 1 ^ 4 1 4 9.4656 1.66 ~ 0.244 “ 
1121 0.0311 0.0429 6.7798 8.2368 0.73 0.553 
1211 0.0239 0.0275 ^ 0 2 5.28 0.83 ~ 0.774 
1212 0.0339 g o 179 ^ 0 2 3.4368 1.94 —0.515 
2212 0.026 0 15.668 |o |N.A. 0.036 
0-5 Reference^ i 丨— 
p=0.16 d a d 
0.4 1B Control h 
n 
0.3 - ( � I — — ^ 
I 試 F f 
0.2 1 ^ 
n i 二 , — _ f ^ P t ^ ^ ^ l r ^ " 严 P=0.77 P=0.51 p=0.03 
} � ^ • ^ L F L ^ r ^ ^ r S 
Q LM , KM , I Wm I mM , r ^ , r : ^ , m 
nil 1112 2211 2221 1121 1211 1212 2212 
Haplotype 
Figure 14. Graphical representation of maximum likelihood algorithm estimated 
haplotype frequency. 2212 was found to be different significantly among case-
control haplotype frequency comparison, due to absence of 2212 control population 
(p=0.036) 
Key: Each number denoted one SNP with: (i) 1 — major allele; (ii) 2 - minor allele. 
They were arranged from 5' to 3，end of AMCase gene: rs3 806448, rs3 806446, 
rs3818822, rs2282290 
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4.2.4 Association of AMCase polymorphism with Atopic Eczema (AE) clinical 
parameters 
Simple linear and binary logistic regressions were studied in this section to 
investigate possible causative relationships between AMCase polymorphisms 
(independent variables) and the clinical parameters measured (dependent variables). 
The clinical parameters include: peripheral blood eosinophil counts, serum IgE level, 
NESS, SCORAD, cutaneous Staphylococcus aureus colonization, as well as SH and 
TEWL. Sex, age and asthma were adjusted as covariates. Additive, co-dominant and 
recessive models were also used to estimate the association. Only significant 
parameters were shown with a suitable model in this thesis. 
The parameters studied by simple linear regression were SCOARD, NESS as 
well as SH and TEWL. They were continuous variables, while the other parameters 
were binary in nature. They were analyzed in terms of skin bacterial carriage, 
peripheral blood eosinophil counts and serum IgE level abnormality among different 
SNPs. 
The abnormality of the non-continuous parameters is defined as below: 
(i) Skin bacterial carriage — only the growth of S. aureus on skin was studied in 
this thesis. No to scanty growth of S. aureus was considered as non-carriers, 
whereas moderate to heavy growth was defined as carriers; 
(ii) Peripheral blood eosinophil counts 一 over 5% of eosinophil in total 
leukocytes count was treated as hypereosinophilia; 
(iii) Serum IgE level - the lower limit of hyper-immunoglobin E for different age 
groups are shown in Table 10. 
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Table 10. Different age groups hyper-immunoglobin E lower limit 
Age (yr) IgE lower threshold (kU/L) 
Newborn - 0.5 16 
>0.5 - <1 27 
>1 - <2 47 
>2 - <3 65 
> 3 - < 4 81 
> 4 - < 6 m 
> 6 - < 8 161 
> 8 |l81 
4.2.4.1 Peripheral blood eosinophil counts 
The percentage of subjects possessing hypereosinophilia under additive 
model was significantly different among rs3806448 polymorphism 0=0.029). The 
additive model assumed that the phenotypic expression would increase with 
additional number of major allele. The increase in SNP major allele increased the 
percentage of AE cases possessing hyper-eosinophil counts, thus, fitting the additive 
model assumption. 
Similar to the binary logistic regression analysis of disease status (AE or 
control), the odds ratio of rs3818822 hypereosinophilia percentage was abnormally 
small in the recessive model. This was because the number of patients possessing 
homozygous minor genotype was very small (n=2). Although there may be a big 
difference presented between subjects possessing homozygous recessive genotype 
with those having at least one major allele, the small sample size may account for the 
insignificant / rva lue (p=0.999). Detailed results are illustrated in Table 11. 
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Table 11. Additive and recessive models in binary logistic regression analysis with 
hypereosinophilia as dependent variable 
Dependent Independent Polymorphism Increased 
variable variable (AE cases / %) Eos / % P value [Odds ratio 
TT (61.0) —93.94 “ Additive model 
rs3806448 TC (33.9) 86.49 P 
Hyper- CC (5.0) ^ 0 . 0 2 9 0.448 
eosinophilia 
r s 3 8 i 8 8 2 2|八八 ( 0 - 9 ) |/ Recessive modd 
|GA + GG (99.1) |/ |0.999 |4.070 XI 
4.2.4.2 Serum immunoglobin E (IgE) level 
The abnormal odds ratio could be interpreted in a similar way as the above. 
The ratio proposed an obvious difference to be presented in percentage of subjects 
possessing hyper-immunoglobin E among rs3818822 polymorphism in recessive 
model. Nevertheless, the difference was not statistically significant. The detailed 
result is illustrated in Table 12. 
Table 12. Recessive model in binary logistic regression analysis with hyper-
immunoglobin E as dependent variable 
Dependent Independent Polymorphism . …， 
.• • . ui /Al； / 0 / � P value Odds ratio variable variable (AE cases / %) ^ 
AA (0.9) 
rs3818822 0.999 8.883x10-9 
immunoglobin E GA + GG (99.1) 
4.2.4.3 Dermatologic factors 
4.2.4.3.1 Cutaneous Staphylococcus aureus colonization 
Evidence had proved that rs2282290 polymorphism (p=0.046) was the 
causative factor of difference in bacterial colonization under the recessive model 
which assumed that the studied phenotype could only be expressed in homozygous 
recessive genotype. The observation was reverse to that of the assumption as the 
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presence of at least one rs2282290 major allele double the percentage of S. aureus 
carriers. 
Similarly, bacterial colonization in the codominant model was significantly 
different from the rs2282290 polymorphism. Significantp values were observed only 
in rs2282290 (1) (p=0.021) analysis. The codominant result suggests a significant 
difference between homozygous dominant and heterozygous genotypes. The detailed 
results are illustrated in Table 13. 
Table 13. Recessive and codominant models in binary logistic regression analysis 
with cutaneous S. aureus colonization as dependent variable 
Dependent Independent Polymorphism S. aureus 
variable variable (AE cases / %) Colonized / % P value jUdds ratio 
训 赠 ， AA (0.9) / Recessive model 
|GA + GG (99.1)1/ |0.999 |6.141xl0-^"— 
. . 2 2 9 0 | G G ( 1 2 . 4 ) [23.81 Recessive model 
^ |AG + AA (87.6) |46.85 |0.046 |2.980 
Cutaneous rs3818822 1/ 1/ Codominant model 
coirration--3818822(1) / / 0-939 [0.971 
rs3818822(2) |/ |/ |0.999 11622046593 
rs2282290 1/ / Codominant m o d e l ~ 
rs2282290(l) 二 二 f,：；； 謝 |2.256 
|rs2282290(2) |/ |/ |Q.248 |O.513 — 
4.2.4.3.2 Skin hydration (SH) and transepidermal water loss (TEWL) 
The recessive model suggested that rs2282290 polymorphism (p=0.032) was 
the causative factor for causing the difference in antecubital skin hydration. A 
significant difference was observed between subjects with homozygous recessive 
genotype and those with at least one major allele. The higher SH of homozygous 
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minor genotype showed the presence of two minor alleles exerted protective effect in 
antecubital area. The detailed result is illustrated in Table 14. 
Table 14. Recessive model in simple linear regression analysis with antecubital SH 
as dependent variable 
D?二ent llndependent IPolymorphism L ±SD Lvalue 
variable variable (AE cases / %) ^ 
GG (12.4) 33.3 ± 11.7 




AE is a common atopic skin disorder that is characterized by chronic 
inflammatory skin condition as well as hypersensitivity towards antigens. As 
childhood AE is common, it would be important to find the possible candidate 
genetic factors, which may increase AE susceptibility and exacerbate disease severity 
in Chinese children. Two recent genetic studies have provided possible clues that 
AMCase plays a key role in developing and sustaining asthmatic airway 
inflammation (Chupp et al, 2007; Zhu et al, 2004). Besides, a canine study provided 
insight on the possible involvements of CHI A in human AE pathogenesis (McCall et 
a l 2001). 
5.1 Data overview 
Our project was the first study to investigate the association of AMCase 
polymorphism and childhood AE. 
A high prevalence of AE among industrialized cities such as Hong Kong 
facilitates the recruitment of subjects. Besides, only Hong Kong residents were 
recruited. This reduces the influences of heterogeneous environmental and ethnic 
confounders. 
Table 7 shows that control group in rs3806448 polymorphism had significant 
p value in HWE. The disequilibrium distribution was due to the complete absence of 
rs3806448 homozygous recessive genotype, CC. The small samples size might be a 
possible cause for the disequilibrium. 
Moreover, differences in minor allele frequency (MAF) between the control 
group and the HapMap Han Chinese were noted (Table 6) (Goldstein et al, 2005). A 
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possible explanation for the differences is that the studied controls were mostly Hong 
Kong southern Chinese, whereas the HapMap samples were Beijing northern 
Chinese. In addition, the number of genotyped subjects (n=192) of this project was 
several folds greater than that of HapMap (n=45), thus, our data should be more 
representative. 
Nevertheless, a number of subjects were found to have other atopic disorders 
among the AE cases. A total of 143 of patients had co-existing allergic rhinitis, while 
77 had asthma or hyperactive airway disease. In order to minimize the manifestation 
of other atopies, asthma was introduced as the covariate in the regression analysis of 
the regression models. 
5.2 AMCase rs3806448 polymorphism was significantly different among AE 
cases and controls 
5.2.1 Allele frequency comparison of AMCase SNPs polymorphisms by chi-
square 
This study identified new association between AE and two AMCase SNPS 
polymorphisms (Table 7). Two SNPs, rs3806448 and rs3 806446, were significantly 
different in the allele frequency comparison between the patients and the control 
group. Whereas, the differences in the allele frequency were insignificant for the 
other SNPs: rs3818822 and rs2282290. This suggested that the promoter is the 
regulatory region that manifested AE susceptibility, instead of the 5'UTR or 
downstream region which rs3818822 and rs2282290 were located. 
SNPs rs2282290 and rs3818822 did not have enough evidence to prove that 
there are significant differences in the case-control allele frequency comparison. 
However, Figure 13 illustrates that there was an elevation of minor allele frequencies 
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for these SNPs, just as the cases of rs3806448 and rs3806446, implying that the 
minor alleles of the four SNPs might be possible causative factors for AE. 
5.2.2 Allele frequency comparison of AMCase SNPs polymorphisms by logistic 
regression analysis 
Nevertheless, binary logistic regression analysis of AE revealed a significant 
value only for rs3806448 (Table 8). The analysis in the recessive model via case-
control comparison reassured rs3806448 polymorphism to be the AE causative factor 
(p=0.001). This was because the SNP in homozygous recessive genotypes greatly 
increased the AE incidence, and showed as enlarged ratio of AE cases against 
controls. The ratio was about one (207:191) in the presence of at least one major 
allele (TC & TT) but the AE number of cases rose to ten folds higher (11:1) than that 
of the controls in the presence of double minor alleles (CC). This highlighted 
rs3806448 homozygous recessive genotype was a susceptible polymorphism to AE. 
Besides, the codominant model was also performed. The model assumed that 
an increasing number of copies of risk allele(s) (C and/or T) would increase 
phenotypic expression of analyzed dependent variables (i.e. AE). The SNPs were 
categorized and compared using homozygous dominant genotypes (TT) as reference 
[TT[ref.] v.s. TC (1) and TT[ref.] v.s. CC (2)]. Insignificant p-value was observed 
with the covariate，rs3 806448 (1). The codominant model with the covariate 
rs3 806448 (1), which compared the phenotypic expression of homozygous dominant 
genotype with that of the heterozygous genotype. The model implied that one minor 
allele did not exert its destructive property that made the subjects more susceptible to 
AE. The covariate rs3806448 (2) differentiated the homozygous dominant phenotype 
with that of the homozygous recessive in the codominant model. A significant p-
value (/?=0.001) and a large odds ratio (OR=52.492) were observed. This confirmed 
54 
that the subjects would be greatly susceptible to AE only if they possessed 
homozygous minor genotypes. 
Asthma was inputted and categorized as the covariate in the model of 
regression analysis, in an attempt to minimize the manifestation by the atopy. This 
provided a possible clue why rs3 806446 polymorphism was significantly associated 
with AE by chi-square analysis but not in the regression models. Marginal 
insignificant association (p=0.067) was observed only with AE when rs3806446 (2) 
served as the covariate with a fair odds ratio (OR=2.959). As a result, rs3806446 
should not be a protent SNP involving in AE development. 
Furthermore, abnormal odds ratios were observed when rs3818822 
polymorphism served as the covariate for the case-control comparison in both the 
recessive and the codominant models. The very large and small odds ratios 
(OR=54670529694 & 1.837x10-") were accompanied by an insignificant p-value 
(p=0.999). This could be explained by the group size of rs3818822 homozygous 
recessive genotype (n=2). An obvious difference between this small group with other 
polymorphism could result in the abnormal odds ratios. 
5.2.3 The possible genetic modification by rs3806448 homozygous recessive 
genotype 
The SNP was located at promoter region, thus, its polymorphism could 
regulate the AMCase gene transcription (Bierbaum et al, 2005; Chatterjee et al, 
2008). In addition, a few other promoter SNPs were in complete linkage 
disequilibrium (LD) with rs3806448. They could alter the gene expression by serving 
as binding sites of potential transcription factors. 
AMCase inhibition in asthmatic mice models could attenuate Th2 
inflammation, airway eosinophilia and bronchial hyperreactivity in response to 
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ovalbumin challenge (Homer et al, 2006). Thus, the AE favouring polymorphism, 
rs3 806448 homozygous recessive genotype was speculated to reduce AMCase gene 
transcription. Thus, the down-regulation of AMCase expression levels may attenuate 
inflammatory condition that might be essential to precipitate AE. The minor alleles 
might also lower the enzymatic activity and result in a similar consequence. 
Nevertheless, the converse was more likely to be true. More and more 
evidence suggested that AMCase upregulation should contribute to the disorder 
(Donnelly et al, 2004). AMCase over-expression was found in the lungs of the 
asthmatic patients but not that of the healthy subjects (Boot et al, 2001; Chupp et al, 
2007; Zhu et al, 2004). In addition, an increased expression of AMCase induced 
airway hyperresponsiveness in the lungs of the ovalbumin sensitized and challenged 
mice (Homer et al, 2006). AMCase inhibition with antisera or allosamidin also 
lowered the number of BAL fluid inflammatory cells of ovalbumin challenged mice 
and decreased airway hyper-responsiveness (Zhou et al’ 2004). 
5.3 Significant difference of haplotype frequency, 2212 among case-control 
comparison 
Max-Delbriick-Centrum (MDC) calculated haplotype frequency from the four 
SNPs, with 1 and 2 denoted as major and minor allele, respectively (Table 8). One of 
the haplotypes, 2212, differed significantly in the case-control comparison due to the 
complete absence of this haplotype in the control as shown in Figure 14. As a result, 
haplotype 2212 was associated with AE. It possessed three minor alleles out of four 
SNPs, and this provided further evidence that the minor alleles of the studied SNPs 
play a role in AE. 
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However, another haplotype — 2221, had insignificant p value (p=0.244). 
Thus, instead of rs3818822, rs2282290 minor allele may increase AE susceptibility 
in combination with rs3806448 and rs3806446 minor alleles. The rs2282290, which 
sited at the downstream region, was speculated to be in complete LD with some other 
regulatory SNPs. Thus, the rs2282290 minor alleles might involve in the AMCase 
expression levels alteration. 
5.4 Strong associations between AMCase SNPs polymorphisms and clinical 
parameters of AE 
Simple linear as well as binary logistic regression analyzes were used to 
analyze the possible causes of AE clinical parameters in three models. These were 
performed via the association study of AMCase SNPs polymorphisms (independent 
variables) with different measured parameters of AE (dependent variables). These 
parameters include: AE severity (SCORAD and NESS), blood eosinophil counts, 
cutaneous S. aureus colonization, serum IgE level as well as peripheral dermatologic 
conditions (SH and TEWL). 
5.4.1 Peripheral blood eosinophil counts 
Eosinophil was an inflammatory marker cell that expressed pruritus 
mediators in Th2 profile. The association between eosinophil and AMCase was 
studied because dysregulation of AMCase could exacerbate Th2 inflammation 
(Lalaker et al, 2009). The SNPs could be pathogenic factors for AE by attenuating 
eosinophil level. 
Over 5% of peripheral blood eosinophil of total leukocytes count was treated 
as hypereosinophilia. The additive model suggested rs3806448 major allele to be the 
causative factor of hypereosinophilia (p=0.029). This was because the model showed 
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an increasing phenotypic expression towards an additional number of rs3806448 
major allele among AE cases (Table 11). The relationship was reassured by an odds 
ratio smaller than one (OR=0.448)，suggesting that the major allele exerted positive 
effect on the phenotypic expression. 
The association between AMCase and eosinophil was shown from: (i) 
y^MCa^e-overexpressed mice attenuated chitin-induced eosinophilic lung 
inflammation (Reese et al, 2007); and (ii) oral and intranasal chitin administrated 
mice before and during immunization of allergens reduced eosinophil levels (Shibata 
et al, 2000; Strong et al, 2002). It is the first time that the relationship, in terms of 
human genetic base, was shown. The result suggested that rs3806448 major allele 
should be the causative SNP polymorphism. The allele enhanced eosinophil levels 
and it subsequently triggered cutaneous inflammation and pruritus. 
However, the homozygous recessive genotype of rs3806448 was suggested to 
be an AE susceptible genotype. This implied that rs3806448 homozygous recessive 
genotype might have increased AE susceptibility via mechanisms other than 
hypereosinophilia. 
5.4.2 Dermatologic factors 
5.4.2.1 Cutaneous Staphylococcus aureus colonization 
A significant difference in S. aureus colonization towards rs2282290 
polymorphism was observed in the recessive model (p=0.046) (Table 13). The 
percentage of S. aureus carriage subjects was doubled in the group that had at least 
one rs2282290 major allele. The harmful functioning of major allele was confirmed 
by its odds ratio (OR=2.980). The possible mechanism of rs2282290 major allele 
resulting in an extensive growth of S. aureus on AE skin lesions required further 
investigation. It was speculated that the loss-of-function of the pathogen degrading 
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enzyme AMCase was a possible cause for the colonization. This was because 
AMCase was a pathogen-degrading enzyme that protected the host by degrading the 
key structural element of pathogens as well as activating host defence through 
pathogen recognition as lectins (Choi et al, 2001). 
Similarly, the codominant model differentiated S. aureus carriage of 
rs2282290 homozygous dominant and that of the heterozygous genotypes. The 
rs2282290 heterozygous genotype was more extensive in S. aureus growth with odds 
ratio 2.256, suggesting that heterozygous instead of homozygous genotypes 
suppressed AMCase activity. The prohibited pathogen degradation and/or host 
defence activation, thus, favoured the growth of S. aureus. 
5.4.2.2 Skin hydration (SH) and transepidermal water loss (TEWL) 
Lastly, the recessive models suggested that the rs2282290 major allele was a 
possible causative factor for skin dryness in the antecubital region (Table 14). This 
was because antecubital SH of subject possessing at least one major allele was 
significantly lower than that of the homozygous recessive genotype (p=0.032). 
Antecubital fossae were often sites for AE to flare up. The susceptible AMCase 
polymorphism rs2282290 major allele predisposed AE by increasing dryness in the 
indicative areas. As skin dryness can induce scratching, this will result in itch-and-
scratch vicious circle (Yarwood et al, 2000). 
5.5 Limitation of the present study 
As mentioned in the introduction section, a wide variation of AE prevalence 
was observed in the cohort that shared similar genetic background. The variation 
could be attributed to environmental factors, such as western life style (Williams et 
al, 1999). Thus, the environment-gene interaction could not be neglected. Any factor 
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exclusion might result in an underestimation or exaggeration of AMCase in AE 
susceptibility and pathogenicity. For instance, hot and damp weather was known to 
aggravate AE, thus, the severity of disease measured in Hong Kong in summer could 
be more severe than that in autumn. This provided a possible explanation for the 
insignificant relationship between AE severity and AMCase SNPs polymorphisms. 
However, it is also possible that the SNPs were associated with AE susceptibility 
only, but not with severity. 
In addition, in this study, we failed to eliminate all the manifestation of other 
atopy, asthma and allergic rhinitis. The presence of other allergic diseases could 
affect the clinical parameters assessed and complicate the association study. Though 
asthma was inputted into the different models of regression analyses in an attempt to 
minimize its manifestation, allergic rhinitis was not adjusted. This was because 
rhinitis was not very accurate as the data were collected through self-reporting by the 
local subjects. 
Our results confirmed that allele frequency distribution of rs3806448 and 
haplotype 2212 were significantly different in case-control comparison. Nevertheless, 
they only accounted for 5.0% and 2.8% of AE, respectively. Obviously, more 
significant AMCase SNP(s) that caused major manifestation of AE, is/are yet to be 
found. The manifestation should greatly increase the AE susceptibility and 
pathogenesis. 
Lastly, the modes of action and functional consequences of these AMCase 
SNPs polymorphisms were not addressed, despite the significant findings stated in 
the previous sections. Alteration in the enzymatic activities and expression levels 
could only be speculated from the SNPs loci and a few related literatures. The result 
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Conclusion and Future Prospect 
6.1 Conclusion 
Childhood AE is one of the most common immunological disorders in Hong 
Kong, thus, research study on predisposing genetic factors is very important. This 
thesis attempted to identify the association of AMCase SNPs polymorphisms and 
childhood AE in Chinese. A total of 218 patients and 192 racially matched controls 
were successfully recruited. Four SNPs were genotyped in all subjects. 
The association of AMCase SNPs and AE was first reported in this project. 
This study revealed the following findings: (i) In terms of allele frequency 
distribution, the results from the binary logistic regression analysis suggested that 
rs3 806448 polymorphism may alter the AMCase expression levels, (ii) the results 
from conducting maximum likelihood algorithm for estimating haplotype frequency 
showed that haplotype 2212 was associated with AE, and (iii) the findings yielded 
from various models of regression analysis seemed to show that rs3806448 and 
rs2282290 polymorphisms were likely the major causative factors for antecubital 
skin dryness, peripheral blood eosinophil level elevation and cutaneous S. aureus 
colonization. 
As a result, our findings support the fact that the AMCase SNPs 
polymorphisms have a significant impact on the susceptibility and pathogenicity of 
childhood AE. 
6.2 Future prospect 
In order to evaluate the detailed mechanisms of AMCase SNPs 
polymorphisms in AE, the number of SNP studies should increase as the most 
62 
significant SNP(s) is/are yet to be found. In addition, the studied SNPs may modulate 
AMCase expression levels and activities. To confirm these speculations, a number of 
studies are proposed as follows. 
At the genetic level, performance of real-time PCR is proposed to investigate 
the effect of SNPs polymorphisms on AMCase expression levels. In addition, gene-
protein interactions should be focused as they may uncover the potential binding 
molecules, which may include silencers, enhancers, as well as transcription 
regulatory factors. They may also up- or down-regulate AMCase expression levels 
through specific loci binding. 
At the protein level, western blotting should be performed to differentiate the 
expression of AMCase among cases and controls. Besides, catalytic site and/or 
stability modification study should also be considered as they may help reveal the 
enzymatic activity. Changes in AMCase expression levels and activities are critical to 
allergen presentation and sensitization. 
Last but not least, skin biopsies should also be performed for conducting 
AMCase histological staining that can help identify AMCase expression levels of 
different cell types. The biopsies staining may also uncover the regulatory cells types, 
via differential expression of AMCase in case-control comparison studies, if any. It is 
believed the aforementioned studies act together and provide possible clues in 





























Supp.l. The position of PGR primers were indicated as [underline], while rs3806448 
and rs3806446 SNPs polymorphisms were highlighted with [*]. Besides, Taq°I 
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restriction enzyme recognition sites were labeled as [ _ ] and cutting sites with [ • • ] 
of AMCase gene promoter region. 
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Supp.2. The position of PCR primers were indicated as [underline], while rs3818822 
SNP polymorphism was highlighted with [*]. Besides, Acul restriction enzyme 
recognition site was labeled as [ _ ] and cutting site with [ • • ] of AMCase 
downstream region. 
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Supp.3. The position of PCR primers were indicated as [underline], while rs2282290 
SNP polymorphism was highlighted with [*]. Besides, XmnI restriction enzyme 
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